Correlation Between Cardio Diagnostics and Tscan Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cardio Diagnostics and Tscan Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardio Diagnostics and Tscan Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cardio Diagnostics Holdings and Tscan Therapeutics, you can compare the effects of market volatilities on Cardio Diagnostics and Tscan Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardio Diagnostics with a short position of Tscan Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardio Diagnostics and Tscan Therapeutics.
Diversification Opportunities for Cardio Diagnostics and Tscan Therapeutics
0.79 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Cardio and Tscan is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Cardio Diagnostics Holdings and Tscan Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tscan Therapeutics and Cardio Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardio Diagnostics Holdings are associated (or correlated) with Tscan Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tscan Therapeutics has no effect on the direction of Cardio Diagnostics i.e., Cardio Diagnostics and Tscan Therapeutics go up and down completely randomly.
Pair Corralation between Cardio Diagnostics and Tscan Therapeutics
Given the investment horizon of 90 days Cardio Diagnostics Holdings is expected to generate 1.96 times more return on investment than Tscan Therapeutics. However, Cardio Diagnostics is 1.96 times more volatile than Tscan Therapeutics. It trades about -0.08 of its potential returns per unit of risk. Tscan Therapeutics is currently generating about -0.25 per unit of risk. If you would invest 82.00 in Cardio Diagnostics Holdings on December 28, 2024 and sell it today you would lose (39.00) from holding Cardio Diagnostics Holdings or give up 47.56% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Cardio Diagnostics Holdings vs. Tscan Therapeutics
Performance |
Timeline |
Cardio Diagnostics |
Tscan Therapeutics |
Cardio Diagnostics and Tscan Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cardio Diagnostics and Tscan Therapeutics
The main advantage of trading using opposite Cardio Diagnostics and Tscan Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardio Diagnostics position performs unexpectedly, Tscan Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tscan Therapeutics will offset losses from the drop in Tscan Therapeutics' long position.Cardio Diagnostics vs. Day One Biopharmaceuticals | Cardio Diagnostics vs. Mirum Pharmaceuticals | Cardio Diagnostics vs. Rocket Pharmaceuticals | Cardio Diagnostics vs. Avidity Biosciences |
Tscan Therapeutics vs. Apellis Pharmaceuticals | Tscan Therapeutics vs. Iteos Therapeutics | Tscan Therapeutics vs. Day One Biopharmaceuticals | Tscan Therapeutics vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |